National Surgical Hospitals Inc-製薬・医療分野:企業M&A・提携分析

◆英語タイトル:National Surgical Hospitals Inc - Pharmaceuticals & Healthcare - Deals and Alliances Profile
◆商品コード:DATA8013354
◆発行会社(調査会社):GlobalData
◆発行日:2017年11月28日
◆ページ数:20
◆レポート言語:英語
◆レポート形式:PDF
◆納品方法:Eメール
◆対象地域:アメリカ
◆産業分野:製薬・医療
◆販売価格オプション(消費税別)
Single UserUSD250 ⇒換算¥37,000見積依頼/購入/質問フォーム
Site License(同一事業所内共有可)USD500 ⇒換算¥74,000見積依頼/購入/質問フォーム
Enterprisewide License(複数事業所内共有可)USD750 ⇒換算¥111,000見積依頼/購入/質問フォーム
販売価格オプションの説明はこちらでご利用ガイドはこちらでご確認いただけます。
※お支払金額は「換算金額(日本円)+消費税+配送料(Eメール納品は無料)」です。
※本体価格が¥30,000未満のレポートにつきましては、ハンドリングチャージ¥5,000が別途かかります。
※Eメールによる納品の場合、通常ご注文当日〜2日以内に納品致します。
※レポート納品後、納品日+5日以内に請求書を発行し、お客様宛に郵送しますので、請求書発行日より2ヶ月以内に振込をお願いします。
※為替レートは適宜修正・更新しております。リアルタイム更新ではありません。
※弊社H&Iグローバルリサーチ株式会社はGlobalData社の日本における正規販売代理店です。同社発行の企業調査レポートに関するお問い合わせは弊社までお願い致します。
GlobalData社の概要はこちらでご確認いただけます。



【レポートの概要】

Summary
National Surgical Hospitals Inc (NSH) is a healthcare organization that owns, operates and manages surgical facilities. The organization’s management services include operational, clinical, information services, managed care services, legal and compliance services, human resource services, supply chain management and financial services. Its managed care services include market assessments, strategy development, portfolio analysis, payor negotiations, contract modeling and analysis, language review, payer audits, and revenue capture. NSH’s legal services include legal research, contract review and drafting, legal coordination and guidance, litigation defense coordination, dispute resolution, acquisitions and member or partner transactions. The organization serves through surgical hospital and ambulatory surgery center. NSH is headquartered in Chicago, Illinois, the US.

National Surgical Hospitals Inc – Pharmaceuticals & Healthcare – Deals and Alliances Profile provides you comprehensive data and trend analysis of the company’s Mergers and Acquisitions (M&As), partnerships and financings. The report provides detailed information on Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnership transactions recorded by the company over a five year period. The report offers detailed comparative data on the number of deals and their value categorized into deal types, sub-sector and regions.

GlobalData derived the data presented in this report from proprietary in-house Pharma eTrack deals database, and primary and secondary research.

Scope

- Financial Deals – Analysis of the company’s financial deals including Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnerships.
- Deals by Year – Chart and table displaying information encompassing the number of deals and value reported by the company by year, for a five year period.
- Deals by Type – Chart and table depicting information including the number of deals and value reported by the company by type such as Mergers and Acquisitions, Equity/Debt Offering etc.
- Deals by Region – Chart and table presenting information on the number of deals and value reported by the company by region, which includes North America, Europe, Asia Pacific, the Middle East and Africa and South and Central America.
- Deals by Sub-sector – Chart and table showing information on the number of deals and value reported by the company, by sub-sector.
- Major Deals – Information on the company’s major financial deals. Each such deal has a brief summary, deal type, deal rationale; and deal financials and target Company’s (major public companies) key financial metrics and ratios.
- Business Description – A brief description of the company’s operations.
- Key Employees – A list of the key executives of the company.
- Important Locations and Subsidiaries – A list and contact details of key centers of operation and subsidiaries of the company.
- Key Competitors – A list of the key competitors of the company.
- Key Recent Developments – A brief on recent news about the company.

Reasons to Buy

Get detailed information on the company’s financial deals that enable you to understand the company’s expansion/divestiture and fund requirements
- The profile enables you to analyze the company’s financial deals by region, by year, by business segments and by type, for a five year period.

Understand the company’s business segments’ expansion / divestiture strategy
- The profile presents deals from the company’s core business segments’ perspective to help you understand its corporate strategy.

Access elaborate information on the company’s recent financial deals that enable you to understand the key deals which have shaped the company
- Detailed information on major recent deals includes a summary of each deal, deal type, deal rationale, deal financials and Target Company’s key financial metrics and ratios.

Equip yourself with detailed information about the company’s operations to identify potential customers and suppliers.
- The profile analyzes the company’s business structure, locations and subsidiaries, key executives and key competitors.

Stay up-to-date on the major developments affecting the company
- Recent developments concerning the company presented in the profile help you track important events.

Gain key insights into the company for academic or business research
- Key elements such as break up of deals into categories and information on detailed major deals are incorporated into the profile to assist your academic or business research needs.

Note*: Some sections may be missing if data is unavailable for the company.

【レポートの目次】

Table of Contents
Table of Contents 3
List of Tables 4
List of Figures 4
National Surgical Hospitals Inc, Pharmaceuticals & Healthcare, Deals By Year, 2011 to YTD 2017 5
National Surgical Hospitals Inc, Pharmaceuticals & Healthcare Deals By Type, 2011 to YTD 2017 6
National Surgical Hospitals Inc, Pharmaceuticals & Healthcare, Deals By Region, 2011 to YTD 2017 7
National Surgical Hospitals Inc, Pharmaceuticals & Healthcare, Deals By Therapy Area, 2011 to YTD 2017 8
National Surgical Hospitals Inc, Medical Devices Deals, 2011 to YTD 2017 9
National Surgical Hospitals Inc, Pharmaceuticals & Healthcare, Deals Summary, 2011 to YTD 2017 10
National Surgical Hospitals Inc, Pharmaceuticals & Healthcare, Deal Details 11
Asset Purchase 11
National Surgical Hospitals Acquires Majority Stake In Lafayette Surgical Specialty Hospital 11
Private Equity 12
Irving Place Capital Acquires National Surgical Hospitals 12
Debt Offering 13
National Surgical Hospitals to Raise up to USD52.5 Million in Private Placement of Notes 13
Acquisition 14
National Surgical Healthcare to Acquire Majority Stake in Optim Healthcare 14
National Surgical Hospitals Acquires Interest in Fairfield Surgery Center 15
National Surgical Hospitals Inc – Key Competitors 16
National Surgical Hospitals Inc – Key Employees 17
National Surgical Hospitals Inc – Locations And Subsidiaries 18
Head Office 18
Other Locations & Subsidiaries 18
Affiliate 19
Appendix 20
Methodology 20
About GlobalData 20
Contact Us 20
Disclaimer 20

List of Tables
National Surgical Hospitals Inc, Pharmaceuticals & Healthcare, Key Facts 2
National Surgical Hospitals Inc, Pharmaceuticals & Healthcare, Deals By Year, 2011 to YTD 2017 5
National Surgical Hospitals Inc, Pharmaceuticals & Healthcare Deals By Type, 2011 to YTD 2017 6
National Surgical Hospitals Inc, Pharmaceuticals & Healthcare, Deals By Region, 2011 to YTD 2017 7
National Surgical Hospitals Inc, Deals By Therapy Area, 2011 to YTD 2017 8
National Surgical Hospitals Inc, Medical Devices Deals, 2011 to YTD 2017 9
National Surgical Hospitals Inc, Pharmaceuticals & Healthcare, Deals Summary, 2011 to YTD 2017 10
National Surgical Hospitals Acquires Majority Stake In Lafayette Surgical Specialty Hospital 11
Irving Place Capital Acquires National Surgical Hospitals 12
National Surgical Hospitals to Raise up to USD52.5 Million in Private Placement of Notes 13
National Surgical Healthcare to Acquire Majority Stake in Optim Healthcare 14
National Surgical Hospitals Acquires Interest in Fairfield Surgery Center 15
National Surgical Hospitals Inc, Key Competitors 16
National Surgical Hospitals Inc, Key Employees 17
National Surgical Hospitals Inc, Other Locations 18
National Surgical Hospitals Inc, Affiliate 19

★海外企業調査レポート[National Surgical Hospitals Inc-製薬・医療分野:企業M&A・提携分析]についてメールでお問い合わせはこちら

■おすすめ企業レポート■
  • Egalet Corp (EGLT):製薬・医療:M&Aディール及び事業提携情報
    Summary Egalet Corp (Egalet) is a specialty pharmaceutical company that develops, manufactures and commercializes novel treatments for pain and other conditions. Its product portfolio includes OXAYDO (oxycodone HCl, USP) tablets CII for the management of acute and chronic moderate to severe pain; SP …
  • NeuroBo Pharmaceuticals Inc (NRBO):企業の財務・戦略的SWOT分析
    NeuroBo Pharmaceuticals Inc (NRBO) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and w …
  • Coolgardie Minerals Ltd (CM1):企業の財務・戦略的SWOT分析
    Coolgardie Minerals Ltd (CM1) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weakne …
  • GP Pharm SA:製薬・医療:M&Aディール及び事業提携情報
    Summary GP Pharm SA (GP Pharm) is a biopharmaceutical company that develops and markets injectables in the areas of oncology and urology. The company provides product portfolio such as injectable dosage forms for the treatment of advanced prostate cancer; nocturnal enuresis and central diabetes insi …
  • Omron Healthcare Co Ltd:医療機器:M&Aディール及び事業提携情報
    Summary Omron Healthcare Co Ltd (Omron Healthcare), a subsidiary of Omron Corp, is a provider of medical equipment for health monitoring and therapy. The company offers blood pressure monitors, digital thermometers, body fat meters, pedometers, nebulizers, body composition monitors and electric toot …
  • Islet Sciences Inc:製薬・医療:M&Aディール及び事業提携情報
    Summary Islet Sciences Inc (Islet Sciences) is a drug development company that develops medicines and technologies for the treatment of metabolic diseases. The company's pipeline products include immune modulating small molecule interleukin 12 inhibitors to address disorders associated with inflamma …
  • Nissan Chemical Corporation:企業の戦略・SWOT・財務分析
    Nissan Chemical Corporation - Strategy, SWOT and Corporate Finance Report Summary Nissan Chemical Corporation - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and ser …
  • Tobira Therapeutics Inc (TBRA)-製薬・医療分野:企業M&A・提携分析
    Summary Tobira Therapeutics Inc (Tobira), formerly Regado Biosciences, Inc, which develops and commercializes therapies for the treatment of to treat non-alcoholic steatohepatitis (NASH) and other liver diseases, inflammation, fibrosis and HIV. Its pipeline products include Cenicriviroc (CVC) and Ev …
  • Ind-Swift Ltd (INDSWFTLTD):企業の財務・戦略的SWOT分析
    Summary Ind-Swift Ltd (Ind-Swift), is a pharmaceutical company that develops, manufactures and markets finished goods dosage, active pharmaceutical ingredients and herbal products. The company offers products such as dispersible tablets, sustained release tablets, mouth dissolving tablets, chewable …
  • PharmAthene Inc (PIP)-製薬・医療分野:企業M&A・提携分析
    Summary PharmAthene Inc (PharmAthene) is a pharmaceutical company that develops and commercializes medical counter measures to biological and chemical weapons. The company’s products include recombinant protective antigen anthrax vaccine, human monoclonal antibody antitoxin and recombinant BChE bios …
  • Po Valley Energy Ltd (PVE):企業の財務・戦略的SWOT分析
    Summary Po Valley Energy Ltd (Po Valley Energy) is an oil and gas company that offers exploration and development of hydrocarbon assets. The company's projects include Sillaro, Castello or Bezzecca, Sant'Alberto, Teodorico and Selva. Its Sillaro field is located in the province of Bologna with seven …
  • Abu Dhabi National Oil Co:企業の戦略的SWOT分析
    Abu Dhabi National Oil Co - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors and major products …
  • Serum Institute of India Ltd:製薬・医療:M&Aディール及び事業提携情報
    Summary Serum Institute of India Ltd (Serum Institute) is a biotechnology company that manufactures and markets vaccines and immuno-biologicals. The company offers products such as bacterial vaccines, viral vaccines, recombinant and combination vaccines, polysaccharide conjugate vaccines, meningococ …
  • Al Rajhi Banking & Investment Corporation (1120):企業の財務・戦略的SWOT分析
    Al Rajhi Banking & Investment Corporation (1120) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key s …
  • Annexon Inc:製薬・医療:M&Aディール及び事業提携情報
    Summary Annexon Inc (Annexon) is a developer of therapeutic products and pathway inhibitors for the treatment of neurological disorders. The company develops treatments for Huntington’s disease and Alzheimer’s disease by targeting complement-mediated neurodegeneration. Its lead drug candidates inclu …
  • Ryanair Holdings Plc (RY4C):企業の財務・戦略的SWOT分析
    Ryanair Holdings Plc (RY4C) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weakness …
  • Cogstate Ltd (CGS):企業の財務・戦略的SWOT分析
    Summary Cogstate Ltd (Cogstate) is a cognitive assessment company that provides technology solutions. The company offers scientific consulting, precision recruitment and computerized assessment, among others. Its clinical trail solutions include computerized cognitive assessment, cogstate prescreen, …
  • Parity Group plc (PTY):企業の財務・戦略的SWOT分析
    Summary Parity Group plc (Parity) is a technology company that offers professional recruitment, IT solutions and consultancy services. The company’s technology solutions include business intelligence, database analytics and development; IT consulting and application management support.The company pr …
  • Stratasys Ltd.:戦略・SWOT・企業財務分析
    Stratasys Ltd. - Strategy, SWOT and Corporate Finance Report Summary Stratasys Ltd. - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and corpora …
  • Occidental Petroleum Corporation:企業の戦略・SWOT・財務情報
    Occidental Petroleum Corporation - Strategy, SWOT and Corporate Finance Report Summary Occidental Petroleum Corporation - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, produ …

◆H&Iグローバルリサーチ株式会社のお客様(例)◆